Sanofi Consumer Healthcare India Limited operates as a fast-moving consumer healthcare company in India. It offers products in the allergy, physical wellness, and pain care segments under brands, such as Allegra, Combiflam, Avil, DePURA, Festal, and Novalgin NU through distributors, wholesalers, government institutions and hospitals, pharmacies, pharmacy chains, and e-commerce. The company was incorporated in 2023 and is based in Mumbai, India. Sanofi Consumer Healthcare India Limited is a subsidiary of Opella Healthcare Participations B.V.
| Current Price | ₹4,670.90 |
|---|---|
| Market Cap | ₹10,757 Cr |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| P/E Ratio | 44.8 |
| Return on Equity | 73.09% |
| Beta (1Y) | 0.2 |
| Dividend Yield | 1.61% |
1. Pharmaceutical Business-100%
Sanofi Consumer Healthcare India Ltd is trading at ₹4,670.90, with a market capitalisation of ₹10,757 Cr.
Sanofi Consumer Healthcare India Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space.
Sanofi Consumer Healthcare India Ltd has a P/E of 44.8 and a return on equity of 73.09%.